Ulisse Biomed Spa
MIL:UBM

Watchlist Manager
Ulisse Biomed Spa Logo
Ulisse Biomed Spa
MIL:UBM
Watchlist
Price: 0.766 EUR -1.03% Market Closed
Market Cap: 16.9m EUR
Have any thoughts about
Ulisse Biomed Spa?
Write Note

Intrinsic Value

The intrinsic value of one UBM stock under the Base Case scenario is 0.641 EUR. Compared to the current market price of 0.766 EUR, Ulisse Biomed Spa is Overvalued by 16%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

UBM Intrinsic Value
0.641 EUR
Overvaluation 16%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Ulisse Biomed Spa

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for UBM cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about UBM?
Bearish
Neutral
Bullish

Fundamental Analysis

0.766 EUR
-1.03%
-1.03%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Ulisse Biomed Spa
IT
Biotechnology
Market Cap
16.7m EUR
IPO
Aug 6, 2021
Employees
-
Italy
Market Cap
16.7m EUR
Industry
Biotechnology
IPO
Aug 6, 2021
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Ulisse Biomed Spa

Provide an overview of the primary business activities
of Ulisse Biomed Spa.

What unique competitive advantages
does Ulisse Biomed Spa hold over its rivals?

What risks and challenges
does Ulisse Biomed Spa face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Ulisse Biomed Spa.

Provide P/S
for Ulisse Biomed Spa.

Provide P/E
for Ulisse Biomed Spa.

Provide P/OCF
for Ulisse Biomed Spa.

Provide P/FCFE
for Ulisse Biomed Spa.

Provide P/B
for Ulisse Biomed Spa.

Provide EV/S
for Ulisse Biomed Spa.

Provide EV/GP
for Ulisse Biomed Spa.

Provide EV/EBITDA
for Ulisse Biomed Spa.

Provide EV/EBIT
for Ulisse Biomed Spa.

Provide EV/OCF
for Ulisse Biomed Spa.

Provide EV/FCFF
for Ulisse Biomed Spa.

Provide EV/IC
for Ulisse Biomed Spa.

Show me price targets
for Ulisse Biomed Spa made by professional analysts.

Compare the intrinsic valuations
of Ulisse Biomed Spa and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Ulisse Biomed Spa against its competitors.

Analyze the profit margins
(gross, operating, and net) of Ulisse Biomed Spa compared to its peers.

Compare the P/E ratios
of Ulisse Biomed Spa against its peers.

Discuss the investment returns and shareholder value creation
comparing Ulisse Biomed Spa with its peers.

Analyze the financial leverage
of Ulisse Biomed Spa compared to its main competitors.

Show all profitability ratios
for Ulisse Biomed Spa.

Provide ROE
for Ulisse Biomed Spa.

Provide ROA
for Ulisse Biomed Spa.

Provide ROIC
for Ulisse Biomed Spa.

Provide ROCE
for Ulisse Biomed Spa.

Provide Gross Margin
for Ulisse Biomed Spa.

Provide Operating Margin
for Ulisse Biomed Spa.

Provide Net Margin
for Ulisse Biomed Spa.

Provide FCF Margin
for Ulisse Biomed Spa.

Show all solvency ratios
for Ulisse Biomed Spa.

Provide D/E Ratio
for Ulisse Biomed Spa.

Provide D/A Ratio
for Ulisse Biomed Spa.

Provide Interest Coverage Ratio
for Ulisse Biomed Spa.

Provide Altman Z-Score Ratio
for Ulisse Biomed Spa.

Provide Quick Ratio
for Ulisse Biomed Spa.

Provide Current Ratio
for Ulisse Biomed Spa.

Provide Cash Ratio
for Ulisse Biomed Spa.

What is the historical Revenue growth
over the last 5 years for Ulisse Biomed Spa?

What is the historical Net Income growth
over the last 5 years for Ulisse Biomed Spa?

What is the current Free Cash Flow
of Ulisse Biomed Spa?

Discuss the annual earnings per share (EPS)
trend over the past five years for Ulisse Biomed Spa.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Ulisse Biomed Spa

Balance Sheet Decomposition
Ulisse Biomed Spa

Current Assets 5.2m
Cash & Short-Term Investments 1.2m
Receivables 1.8m
Other Current Assets 2.1m
Non-Current Assets 23.4m
Long-Term Investments 6.1k
PP&E 2.3m
Intangibles 21.1m
Other Non-Current Assets -10
Current Liabilities 2.4m
Accounts Payable 1.2m
Other Current Liabilities 1.2m
Non-Current Liabilities 1.4m
Other Non-Current Liabilities 1.4m
Efficiency

Earnings Waterfall
Ulisse Biomed Spa

Revenue
420.9k EUR
Cost of Revenue
-1.9m EUR
Gross Profit
-1.4m EUR
Operating Expenses
-3.2m EUR
Operating Income
-4.6m EUR
Other Expenses
-16.8k EUR
Net Income
-4.6m EUR

Free Cash Flow Analysis
Ulisse Biomed Spa

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

UBM Profitability Score
Profitability Due Diligence

Ulisse Biomed Spa's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

Exceptional 1-Year Revenue Growth
Negative Operating Income
Negative Net Income
Negative ROE
17/100
Profitability
Score

Ulisse Biomed Spa's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

UBM Solvency Score
Solvency Due Diligence

Ulisse Biomed Spa's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Average Altman Z-Score
66/100
Solvency
Score

Ulisse Biomed Spa's solvency score is 66/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

UBM Price Targets Summary
Ulisse Biomed Spa

Wall Street analysts forecast UBM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for UBM is 1 EUR with a low forecast of 0.99 EUR and a high forecast of 1.029 EUR.

Lowest
Price Target
0.99 EUR
29% Upside
Average
Price Target
1 EUR
30% Upside
Highest
Price Target
1.029 EUR
34% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for UBM?

Click here to dive deeper.

Dividends

Ulisse Biomed Spa
does not pay dividends
Shareholder Yield

Current shareholder yield for UBM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one UBM stock?

The intrinsic value of one UBM stock under the Base Case scenario is 0.641 EUR.

Is UBM stock undervalued or overvalued?

Compared to the current market price of 0.766 EUR, Ulisse Biomed Spa is Overvalued by 16%.

Back to Top